A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4180-4184

  Guan, Li Shuang ^a   Liu, Jia Jia ^b   Xu, Yong Hua ^b   Wang, Zhao Yi ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA;

ARTICLE; CHILDHOOD CANCER; DNA BINDING; EMBRYO; EXON; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROBLASTOMA; POINT MUTATION; PRIORITY JOURNAL; SOLID TUMOR; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ALTERNATIVE SPLICING; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; EXONS; GENES, REPORTER; GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; POINT MUTATION; WILMS TUMOR;

EID: 0032530619     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Beckwith, J. B., Kiviat, N. B., and Bonadio, J. F. Nephrogenic rest, nephroblastomatosis and the pathogenesis of Wilms' tumor. Pediatr. Pathol., 10: 1-36, 1990.
2. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., Jones, C., and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
3. Gessler, M., Poutska, A., Cavenee, W., Neve, R. L., Orkin, S. H., and Bruns, G. A. Homozygous deletion in Wilms' tumors of a zinger finger gene identified by chromosome jumping. Nature (Lond.) 343: 774-778, 1990.
4. Bonetta, L., Kuehn, S. E., Huang, A., Law, D. J., Kalikin, L. M., Koi, M., Reeve, A. E., Brownstein, B. H., Yeger, H., Williams, B. R. G., and Feingberg, A. P. Wilms' tumor locus on 11p13 defined by multiple CpG island associated transcripts. Science (Washington DC), 250: 994-997, 1990.
5. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms' tumor gene. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
6. Rauscher, F. J., III, Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
7. Wang, Z. Y., Qiu, Q-Q., Gurrieri, M., Huang, J., and Deuel, T. F. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene, 10: 415-422, 1995.
8. Madden, S. L., Cook, D. M., Morris, J. F., Cashler, A., Sukhatme, V. K., and Rauscher, F. J., III. Transcriptional repression mediated by WT1 the Wilms' tumor gene product. Science (Washington DC), 253: 1550-1553, 1991.
9. Wang, Z. Y., Madden, S. L., Deuel, T. F., and Rauscher, F. J., III. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem., 267: 21999-22002, 1992.
10. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J., III. Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor, WT1. Science (Washington DC), 257: 674-678, 1992.
11. Englert, C., Hou, X-Y., Maheswaran, S., Bennett, P., Ngwu, C., Re, G. G., Garvin, A. J., Rosner, M. R., and Haber, D. A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J., 14: 4662-4675, 1995.
12. Rupprecht, H. D., Drummond, I. A., Madden, S. L., Rauscher, F. J., III, and Sukhatme, V. P. The Wilms' tumor suppressor WT1 is negatively autoregulated. J. Biol. Chem., 269: 6198-6206, 1994.
13. Haber, D. A., Park, S., Maheswaran, S., Englert, C., Re, G. G., Hazen-Martin, D. J., Sens, D. A., and Garvin, J. WT1-mediated growth suppression of Wilms'tumor cells expressing a WT1 splicing variant. Science (Washington DC), 262: 2057-2059, 1993.
14. Cowell, J. K., Wadey, R. B., Haber, D. A., Call, K. M., Housman, D. E., and Pritchard, J. K. Structural rearrangements of the WT1 gene in Wilms' tumor cells. Oncogene, 6: 595-599, 1991.
15. Haber, D. A., Buckler, A. J., Glaser, T., Call, K. M., Pelletier, J., Sohn, R. L., Douglass, E. C., and Housman, D. E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61: 1257-1269, 1990.
16. Huff, V., Miwa, H., Haber, D. A., Call, K. M., Housman, D. E., Strong, L. C., and Saunders, G. F. Evidence for WT1 as a Wilms' tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am. J. Hum. Genet., 48: 997-1003, 1991.
17. Pelletier, J., Bruening, W., Li, F. P., Haber, D. A., Glaser, T., and Housman, D. E. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumor. Nature (Lond.), 353: 431-434, 1991.
18. Pelletier, J., Bruening, W., Kashton, C. E., Maver, S. M., Manivel, J. C. Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., Fouser, L., Fine, R. N., Silverman, B. L., Haber, D. A., and Housman, D. E. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67: 437-447, 1991.
19. Little, M., and Wells, C. A clinical overview of WT1 gene mutations. Hum. Mutat., 9: 209-225, 1997.
20. Reddy, J. C., and Licht, J. D. The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochem. Biophys. Acta, 1287: 1-28, 1996.
21. Hewitt, S. M., and Saunders, G. F. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function. Anticancer Res., 16: 621-626, 1996.
22. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
23. Noonan, K. E., and Roninson, I. B. mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res., 16: 10366, 1988.
24. Brown, K. W., Watson, J. E., Poirier, V., Mott, M. G., Berry, P. J., and Maitland, N. J. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene, 7: 763-768, 1992.
25. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Supplement 36 of Current Protocols in Molecular Biology. New York: John Wiley & Sons, Inc., 1996.
26. Park, S., Tomlinson, G., Nisen, P., and Haber, D. A. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Cancer Res., 153: 4757-4760, 1993.
27. Simms, L. A., Algar, E. M., and Smith, P. J. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumor. Eur. J. Cancer, 31: 2270-2276, 1995.
28. Kudoh, T., Ishidate, T., Moriyama, M., Toyoshima, K., and Akiyama, T. G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc. Natl. Acad. Sci. USA, 92: 4517-4521, 1995.